Celltrion - M&A Summary and Business Overview

Life ScienceCompany

Celltrion M&A Summary

Celltrion has acquired 2 companies, including 2 in the last 5 years.

Celltrion’s largest acquisition to date was in 2020, when it acquired Takeda Pharmaceutical - Primary Care Product Assets for $278M. Celltrion has acquired in 2 countries. The Company’s most targeted sectors include life science (100%).

Celltrion Business Overview

Where is Celltrion headquartered?

Celltrion is headquartered in Incheon, South Korea.

What is Celltrion’s revenue?

Celltrion disclosed revenue of 2,176,432M KRW for 2023 and 2,283,967M KRW for 2022.

How many employees does Celltrion have?

Celltrion has 2,391 employees.

What sector is Celltrion in?

Celltrion is a life science company.

When was Celltrion founded?

Celltrion was founded in 2002.

M&A Summary

  • M&A Total Activity2
    • M&A Buy Activity2
  • Total Sectors Invested 1
  • Total Countries Invested 2
  • M&A Buy/Sell Connections 1

Celltrion

Celltrion, Inc.

23 Academy-ro Yeonsu-gu,
Incheon,
South Korea,
+82 3 2850 5000
www.celltrion.com

Celltrion is a biopharmaceutical company specializing in the development of “biosimilars” for monoclonal antibody drugs. Celltrion provides biosimilars for auto-immune diseases and various cancers; generic pharmaceuticals; and covid-19 test kits. Celltrion was incorporated in 2002 and is based in Incheon, South Korea.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.4/yr) # - 1 - - - 1 2
vol $278M $278M
Sell (0.0/yr) # - - - - - - 0
  2

Most Recent M&A

Company Date Value Type
iQone Healthcare Switzerland 2024-11-14 - Add-on Acquisition
Versoix, Switzerland · www.iqone-healthcare.com
Takeda Pharmaceutical Co.,Ltd. - Primary Care (PC) Product Assets 2020-11-30 278M USD Divestiture
Osaka, Japan
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 2 (100%) 278M (100%) - -
Total 2 $278M - -

By Geo

State/Country Buy Value Sell Value
Japan 1 278M - -
Switzerland 1 - - -
Domestic - - - -
Cross-border 2 (100%) 278M (100%) - -
Total 2 $278M - -

Deal Values

buy # Total
$100M to $1B 1 $278M
TOTAL $278M
Largest Takeda Pharmaceutical Co.,Ltd. - Primary Care (PC) Product Assets
$278M (2020-11-30)

M&A Connections

Deals
Acquired from
Strategic(s)
50%
1 (50%)

 Subscribe to unlock this and 208,934
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 204K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Celltrion

Life Science Companies , South Korea Companies